US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 368.430
  • -4.380-1.17%
Close Oct 18 16:00 ET
  • 366.000
  • -2.430-0.66%
Post 20:02 ET
16.39BMarket Cap16.93P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

United Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 727.534M--
--2024/Q3-- / 722.907M--
Jul 31, 20242024/Q2714.900M / 691.867M--
May 1, 20242024/Q1677.700M / 624.194M--
Feb 21, 20242023/Q4614.700M / 575.874M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 727.534M--
--2024/Q3-- / 722.907M--
Jul 31, 20242024/Q2714.900M / 691.867M--
May 1, 20242024/Q1677.700M / 624.194M--
Feb 21, 20242023/Q4614.700M / 575.874M--

Unlock Free Earnings Estimates

United Therapeutics Earnings Reports

  • United Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 06:34 ET

  • United Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 1 06:34 ET

  • United Therapeutics | 10-K: FY2023 Annual Report

    Feb 21 06:06 ET

  • United Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 06:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 8, 2024

    Buy

    • Buy

      69.23%

    • Hold

      23.08%

    • Sell

      7.69%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data